Stock 4574 TAIKO PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Taiko Pharmaceutical Co.,Ltd.

Equities

4574

JP3442200006

Market Closed - Japan Exchange
Other stock markets
 07:00:00 30/05/2024 BST 		5-day change 1st Jan Change
367 JPY +1.38% Intraday chart for Taiko Pharmaceutical Co.,Ltd. -1.34% +21.12%
05-10 Taiko Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024 CI
02-09 Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Taiko Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024
CI
Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2024
CI
Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023.
CI
Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2023
CI
Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2023.
CI
Kingworld Medicines Subsidiary Buys Shares in Taiko Pharmaceutical
MT
Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2023
CI
Cuorips Inc. has completed an IPO in the amount of ¥3.432 billion.
CI
Taiko Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Kingworld Medicines to Invest 832 Million Yen in Taiko Pharmaceutical
MT
Taiko Pharmaceutical to Pay 607 Million Yen Penalty; Shares Down 3%
MT
Easing Wholesale Inflation Strengthens Japanese Shares; Orix, Partners Near Government Approval for Japan's First Casino Resort
MT
Taiko Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 2023
CI
Taiko Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022
CI
Taiko Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Year ending December 31, 2022
CI
Taiko Pharmaceutical Co.,Ltd. Omits to Pay Year-End Dividend for the Year Ended December 31, 2021
CI
Taiko Pharmaceutical Co.,Ltd. acquired Torishi S.A. de C.V.
CI
Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Quarter End December 2021
CI
Certain Common Stock of Almado, Inc. are subject to a Lock-Up Agreement Ending on 21-SEP-2021.
CI
Taiko Pharmaceutical Co.,Ltd. Announces Earnings Results for the Second Quarter of 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4574 Stock
  4. News Taiko Pharmaceutical Co.,Ltd.